Giuseppe Emmanuele Umana

Neurosurgeon, Mixed Reality, ApoQlar, Holomedicine association, Tor Vergata University, Cannizzaro Hospital, Catania, Italy

[siciliaweb @Lasiciliaweb]

Catania: via Etnea questa sera (foto Roberto Viglianisi) #catania #sicilia #sicily #italia #italy

[Claudia Gonzaga-Jauregui @cgonzagaj]

"Bullying is a means for mediocre scientists to rise to the top. Some star academics reached their position because they are bullies, not in spite of it." - Excellent piece about bullying in academia (and really any other professional environment). https://t.co/JTqGBaAuuf

[Paolo Palmisciano, MD @PaoloPalmiscia1]

Extremely honored and excited for what comes next!
#Neurosurgery #Match2023

[Paolo Palmisciano, MD @PaoloPalmiscia1]

We made it!

[siciliaweb @Lasiciliaweb]

Etna: Rifugio Sapienza in questo momento (foto Alessandro Fardella) #etna #sicilia #sicily #italia #italy

[Dr. Glaucomflecken @DGlaucomflecken]

An American experiences universal health care

[Babak Kateb @BabakKateb]

July 1st 2022 USKUDAR university visit-1st Middle East Brain initiative summit ⁦@uskudaruni_en⁩ ⁦@WorldBrainMap⁩ ⁦@drnevzattarhan⁩ ⁦@BabakKateb⁩ ⁦⁦@brainmappingfnd⁩

[Paolo Palmisciano, MD @PaoloPalmiscia1]

Enthusiastic to see our protocol on the ongoing SMS study on venous alterations after aSAH published in @FrontiersIn!
Honored to be involved in collaborating with such amazing institutions worldwide!
@GiuseppeUmana @ottavio_80
Link -> https://t.co/KUAjxRWnt8

[Paolo Palmisciano, MD @PaoloPalmiscia1]

Extremely happy to see our review on endocrine disorders after upfront GKRS for pituitary adenomas out in #Pituitary. A personal goal!

Huge thanks to @GiuseppeUmana @ctogasawara @AliHaiderTX @Obinalamer and all co-authors.

Link -> https://t.co/Is87tpTi3M

[Paolo Palmisciano, MD @PaoloPalmiscia1]

Honored to have presented our collaborative research projects at @NASBSorg and @spinesection these past two weeks.

Grateful to be part of such an amazing research group @AliHaiderTX @telahmadieh @Obinalamer @sagoo_navraj @GiuseppeUmana @SalahGAoun and the rest of the team!

[Giuseppe Emmanuele Umana @GiuseppeUmana]

Dear colleagues, we are happy to inform you that our editorial project on "Surgical Management of Junctional Spinal Disorders" is active!
Looking forward to receive your valuable contributions:
https://t.co/gRLTEoxrTn

[Paolo Palmisciano, MD @PaoloPalmiscia1]

Happy to see our paper on posterior epidural disc migration published in #JOCN.
Grateful to @GiuseppeUmana, @AliHaiderTX, @sagoo_navraj, @Obinalamer , @SalahGAoun and all co-authors for their mentorship and support.

https://t.co/94zf6mzIvB

[Paolo Palmisciano, MD @PaoloPalmiscia1]

I am very grateful for this opportunity and to be working with such amazing team.
@UCNeurosurgery

[Frontiers - Oncology @FrontOncology]

🔥 #5: Intraoperative Ultrasound: Emerging Technology and Novel Applications in #BrainTumor #Surgery

👩‍⚕️👨‍⚕️ Giuseppe Roberto Giammalva, Gianluca Ferini et al.

Read #OpenAccess 👉 https://t.co/QzdmmfDpfm

@GiuseppeUmana @PaoloPalmiscia1 @unipa_it #BTsm #NeuroOnc #NeuroSurgery

[Salah G. Aoun @SalahGAoun]

Check out our last review:
Proud to be part of this awesome research team!

https://t.co/oOaP8P2xJn
@AliHaiderTX @PaoloPalmiscia1

[Paolo Palmisciano, MD @PaoloPalmiscia1]

Great to see our paper on Leptomeningeal metastases of the spine finally out in #Anticancer Research!
Huge thanks to @AliHaiderTX, @sagoo_navraj, @Obinalamer, @GiuseppeUmana, @SalahGAoun!

https://t.co/6MsWWXbyNo

[Giuseppe Emmanuele Umana @GiuseppeUmana]

@PeterMLawrence1 @FrontSurgery @FrontiersIn Special thanks to @ottavio_80 and @ilariabondi

[Peter M. Lawrence @PeterMLawrence1]

New article published in @FrontSurgery Neuroscience, @FrontiersIn by @GiuseppeUmana et al
Full article can be accessed here: https://t.co/4K0SQUVYht

[Paolo Palmisciano, MD @PaoloPalmiscia1]

Check out our recent review on Orbital Metastases published on @Cancers_MDPI!
Great reading for these holidays!
Special thanks to ⁦@AliHaiderTX⁩, ⁦@telahmadieh⁩, and ⁦@GiuseppeUmana⁩ for their mentorship. https://t.co/intECJgFfv